Parathyroid Hormone 1-34(Teriparatide) Treatment in Pelvic Insufficiency Fractures - A Report of Two Cases -

Abstract

As a result of aging population, the incidence of pelvic insufficiency fracture has been increasing. Pain-related immobility caused by pelvic insufficiency fractures may result in a serious dependency and high mortality with preexisting comorbidities. We present two cases of pelvic insufficiency fracture in elderly patients which had good clinical outcome by parathyroid hormone 1-34(teriparatide) treatment as well as a literature review.

DOI: 10.11005/jbm.2012.19.2.147

Extracted Key Phrases

4 Figures and Tables

Cite this paper

@inproceedings{Moon2012ParathyroidH1, title={Parathyroid Hormone 1-34(Teriparatide) Treatment in Pelvic Insufficiency Fractures - A Report of Two Cases -}, author={Sang-Won Moon and Dong-Hyun Lee and Young-Chang Kim and Young-Bok Kim and Sang-Jin Lee and Ji Wan Kim}, booktitle={Journal of bone metabolism}, year={2012} }